550 related items for PubMed ID: 16632013
1. Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study.
Li PK, Leung CB, Chow KM, Cheng YL, Fung SK, Mak SK, Tang AW, Wong TY, Yung CY, Yung JC, Yu AW, Szeto CC, HKVIN Study Group.
Am J Kidney Dis; 2006 May; 47(5):751-60. PubMed ID: 16632013
[Abstract] [Full Text] [Related]
2. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
Philipp T, Smith TR, Glazer R, Wernsing M, Yen J, Jin J, Schneider H, Pospiech R.
Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
[Abstract] [Full Text] [Related]
3. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN.
Circulation; 2009 Oct 20; 120(16):1577-84. PubMed ID: 19805651
[Abstract] [Full Text] [Related]
4. Efficacy and safety of valsartan, an angiotensin II receptor antagonist, in hypertension after renal transplantation: a randomized multicenter study.
Andrés A, Morales E, Morales JM, Bosch I, Campo C, Ruilope LM, Valsartan in Renal Transplantation Group.
Transplant Proc; 2006 Oct 20; 38(8):2419-23. PubMed ID: 17097955
[Abstract] [Full Text] [Related]
5. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
Ruilope LM, Aldigier JC, Ponticelli C, Oddou-Stock P, Botteri F, Mann JF.
J Hypertens; 2000 Jan 20; 18(1):89-95. PubMed ID: 10678548
[Abstract] [Full Text] [Related]
6. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z, Amlodipine Versus Enalapril in Renal failure (AVER) Study Group.
Clin Ther; 2008 Mar 20; 30(3):482-98. PubMed ID: 18405787
[Abstract] [Full Text] [Related]
7. Effects of valsartan on the progression of chronic renal insufficiency in patients with nondiabetic renal diseases.
Ishimitsu T, Kameda T, Akashiba A, Takahashi T, Ando N, Ohta S, Yoshii M, Inada H, Tsukada K, Minami J, Ono H, Matsuoka H.
Hypertens Res; 2005 Nov 20; 28(11):865-70. PubMed ID: 16555574
[Abstract] [Full Text] [Related]
8. Diuretic uptitration with half dose combined ACEI + ARB better decreases proteinuria than combined ACEI + ARB uptitration.
Esnault VL, Ekhlas A, Nguyen JM, Moranne O.
Nephrol Dial Transplant; 2010 Jul 20; 25(7):2218-24. PubMed ID: 20106824
[Abstract] [Full Text] [Related]
9. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
Perkins RM, Aboudara MC, Uy AL, Olson SW, Cushner HM, Yuan CM.
Am J Kidney Dis; 2009 Apr 20; 53(4):606-16. PubMed ID: 19216016
[Abstract] [Full Text] [Related]
10. IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria.
Coppo R, Peruzzi L, Amore A, Piccoli A, Cochat P, Stone R, Kirschstein M, Linné T.
J Am Soc Nephrol; 2007 Jun 20; 18(6):1880-8. PubMed ID: 17513327
[Abstract] [Full Text] [Related]
11. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
Manno C, Torres DD, Rossini M, Pesce F, Schena FP.
Nephrol Dial Transplant; 2009 Dec 20; 24(12):3694-701. PubMed ID: 19628647
[Abstract] [Full Text] [Related]
12. Spironolactone in type 2 diabetic nephropathy: Effects on proteinuria, blood pressure and renal function.
van den Meiracker AH, Baggen RG, Pauli S, Lindemans A, Vulto AG, Poldermans D, Boomsma F.
J Hypertens; 2006 Nov 20; 24(11):2285-92. PubMed ID: 17053552
[Abstract] [Full Text] [Related]
13. Valsartan combined with clopidogrel and/or leflunomide for the treatment of progressive immunoglobulin A nephropathy.
Cheng G, Liu D, Margetts P, Liu L, Zhao Z, Liu Z, Tang L, Fang Y, Li H, Guo Y, Chen F, Liu F.
Nephrology (Carlton); 2015 Feb 20; 20(2):77-84. PubMed ID: 25358874
[Abstract] [Full Text] [Related]
14. Beneficial effects of olmesartan and temocapril on urinary liver-type fatty acid-binding protein levels in normotensive patients with immunoglobin A nephropathy.
Nakamura T, Inoue T, Sugaya T, Kawagoe Y, Suzuki T, Ueda Y, Koide H, Node K.
Am J Hypertens; 2007 Nov 20; 20(11):1195-201. PubMed ID: 17954367
[Abstract] [Full Text] [Related]
15. Effect of baseline and changes in systolic blood pressure over time on the effectiveness of valsartan in the Valsartan Heart Failure Trial.
Anand IS, Rector TS, Kuskowski M, Thomas S, Holwerda NJ, Cohn JN.
Circ Heart Fail; 2008 May 20; 1(1):34-42. PubMed ID: 19808268
[Abstract] [Full Text] [Related]
16. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
Clin Ther; 2007 Feb 20; 29(2):279-89. PubMed ID: 17472820
[Abstract] [Full Text] [Related]
17. Clinical trial to evaluate omega-3 fatty acids and alternate day prednisone in patients with IgA nephropathy: report from the Southwest Pediatric Nephrology Study Group.
Hogg RJ, Lee J, Nardelli N, Julian BA, Cattran D, Waldo B, Wyatt R, Jennette JC, Sibley R, Hyland K, Fitzgibbons L, Hirschman G, Donadio JV, Holub BJ, Southwest Pediatric Nephrology Study Group.
Clin J Am Soc Nephrol; 2006 May 20; 1(3):467-74. PubMed ID: 17699247
[Abstract] [Full Text] [Related]
18. Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes.
Estacio RO, Coll JR, Tran ZV, Schrier RW.
Am J Hypertens; 2006 Dec 20; 19(12):1241-8. PubMed ID: 17161769
[Abstract] [Full Text] [Related]
19. Safety and efficacy of antihypertensive therapy with add-on angiotensin II type 1 receptor blocker after successful coronary stent implantation.
Sugihara M, Miura S, Takamiya Y, Kiya Y, Arimura T, Iwata A, Kawamura A, Nishikawa H, Uehara Y, Saku K.
Hypertens Res; 2009 Jul 20; 32(7):625-30. PubMed ID: 19461652
[Abstract] [Full Text] [Related]
20. Antiproteinuric response to dual blockade of the renin-angiotensin system in primary glomerulonephritis: meta-analysis and metaregression.
Catapano F, Chiodini P, De Nicola L, Minutolo R, Zamboli P, Gallo C, Conte G.
Am J Kidney Dis; 2008 Sep 20; 52(3):475-85. PubMed ID: 18468748
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
